Radiological features of head and neck mammary analogue secretory carcinoma: 11 new cases with a systematic review of 29 cases reported in 28 publications.

Head and neck Magnetic resonance imaging Mammary analogue secretory carcinoma Salivary gland Systematic review

Journal

Neuroradiology
ISSN: 1432-1920
Titre abrégé: Neuroradiology
Pays: Germany
ID NLM: 1302751

Informations de publication

Date de publication:
Nov 2021
Historique:
received: 08 07 2021
accepted: 17 08 2021
pubmed: 25 8 2021
medline: 25 2 2023
entrez: 24 8 2021
Statut: ppublish

Résumé

This retrospective study aimed to investigate the radiological features of head and neck mammary analogue secretory carcinoma (MASC) and systematically review previous publications and 11 new cases. We included patients with pathologically proven MASCs with preoperative CT or MRI images, including 11 patients from our hospital and 29 patients from 28 publications extracted after screening 645 abstracts. Two board-certified radiologists reviewed and evaluated all radiological images. The frequency of metastasis during the follow-up period in tumors with well- and ill-defined margins was compared using a Fisher's exact test. The median age at diagnosis was 52.5 years (range, 7-78 years; 20 males). Of the 40 patients, those in their 50 s were the most common (10/40, 25.0%), and the main tumor site was the parotid gland (27/40, 42.5%). Characteristic radiological features included high intensity on T1WI in the cystic components and tumors frequently showed "papillary and cystic," which showed a projection into the cystic components, or "non-papillary and cystic" morphology, which did not show projection of the solid components. Tumor metastasis was found in 10/35 patients (28.6%) during the follow-up period, with a significant difference in frequency between the tumors with well- and ill-defined margin (well-defined (4/26) vs. ill-defined (6/9); P = 0.0074). MASCs are newly recognized malignant tumors. Characteristic T1WI high intensity on MRI and predominant cystic morphology may reflect its unique histological profile. Ill-defined tumor margin status was related to frequent metastasis. Awareness of these characteristic radiological features can assist radiologists in better detection of this novel entity.

Identifiants

pubmed: 34427706
doi: 10.1007/s00234-021-02796-7
pii: 10.1007/s00234-021-02796-7
doi:

Substances chimiques

Biomarkers, Tumor 0

Types de publication

Case Reports Journal Article Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

1901-1911

Informations de copyright

© 2021. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Références

Seethala RR, Stenman G (2017) Update from the 4th Edition of the World Health Organization Classification of Head and Neck Tumours: tumors of the salivary gland. Head Neck Pathol 11:55–67. https://doi.org/10.1007/s12105-017-0795-0
Skálová A, Vanecek T, Sima R et al (2010) Mammary analogue secretory carcinoma of salivary glands, containing the ETV6-NTRK3 fusion gene: a hitherto undescribed salivary gland tumor entity. Am J Surg Pathol 34:599–608. https://doi.org/10.1097/PAS.0b013e3181d9efcc
doi: 10.1097/PAS.0b013e3181d9efcc pubmed: 20410810
Skálová A, Gnepp DR, Lewis JS Jr et al (2017) Newly described entities in salivary gland pathology. Am J Surg Pathol 41:e33–e47. https://doi.org/10.1097/PAS.0000000000000883
doi: 10.1097/PAS.0000000000000883 pubmed: 28614209
Connor A, Perez-Ordoñez B, Shago M et al (2012) Mammary analog secretory carcinoma of salivary gland origin with the ETV6 gene rearrangement by FISH: expanded morphologic and immunohistochemical spectrum of a recently described entity. Am J Surg Pathol 36:27–34
doi: 10.1097/PAS.0b013e318231542a
Khalele BA (2017) Systematic review of mammary analog secretory carcinoma of salivary glands at 7 years after description. Head Neck 39:1243–1248. https://doi.org/10.1002/hed.24755
doi: 10.1002/hed.24755 pubmed: 28370824
Kashiwagi N, Nakatsuka SI, Murakami T et al (2018) MR imaging features of mammary analogue secretory carcinoma and acinic cell carcinoma of the salivary gland: a preliminary report. Dentomaxillofac Radiol 47:20170218. https://doi.org/10.1259/dmfr.20170218
doi: 10.1259/dmfr.20170218 pubmed: 29493279 pmcid: 6196047
Page MJ, McKenzie JE, Bossuyt PM et al (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 372:n71. https://doi.org/10.1136/bmj.n71
doi: 10.1136/bmj.n71 pubmed: 33782057 pmcid: 8005924
Murad MH, Sultan S, Haffar S, Bazerbachi F (2018) Methodological quality and synthesis of case series and case reports. BMJ Evid Based Med 23:60–63. https://doi.org/10.1136/bmjebm-2017-110853
doi: 10.1136/bmjebm-2017-110853 pubmed: 29420178 pmcid: 6234235
Helmy D, Chang J, Bishop JW et al (2020) MR imaging findings of a rare pediatric parotid tumor: Mammary analogue secretory carcinoma. Radiol Case Rep 15:1460–1463. https://doi.org/10.1016/j.radcr.2020.05.035
doi: 10.1016/j.radcr.2020.05.035 pubmed: 32642018 pmcid: 7334559
Gupta K, Patwa HS, Niehaus AG et al (2019) Mammary analogue secretory carcinoma presenting as a cystic parotid mass. Radiol Case Rep 14:1103–1108. https://doi.org/10.1016/j.radcr.2019.06.019
doi: 10.1016/j.radcr.2019.06.019 pubmed: 31338135 pmcid: 6629920
Tokuzen N, Goda H, Nakashiro K (2019) Locally advanced mammary analogue secretory carcinoma of the parotid gland. Int J Oral Maxillofac Surg 48:865–868. https://doi.org/10.1016/j.ijom.2019.01.027
doi: 10.1016/j.ijom.2019.01.027 pubmed: 30777712
Sun L, Thorson T, Zhu R et al (2019) A case report of parotid mammary analogue secretory carcinoma and reviews. Int J Surg Case Rep 55:88–91. https://doi.org/10.1016/j.ijscr.2019.01.004
doi: 10.1016/j.ijscr.2019.01.004 pubmed: 30716709 pmcid: 6360266
Shigeta R, Orgun D, Mizuno H, Hayashi A (2018) Mammary analogue secretory carcinoma arising in the parotid gland of child. Plast Reconstr Surg Glob Open 6:e2059. https://doi.org/10.1097/GOX.0000000000002059
doi: 10.1097/GOX.0000000000002059 pubmed: 30656126 pmcid: 6326613
Desai MA, Mehrad M, Ely KA et al (2019) Secretory carcinoma of the thyroid gland: report of a highly aggressive case clinically mimicking undifferentiated carcinoma and review of the literature. Head Neck Pathol 13:562–572. https://doi.org/10.1007/s12105-018-0995-2
doi: 10.1007/s12105-018-0995-2 pubmed: 30564997
Mossinelli C, Pigni C, Sovardi F et al (2019) Synchronous parotid (mammary analog) secretory carcinoma and acinic cell carcinoma: report of a case. Head Neck Pathol 13:686–691. https://doi.org/10.1007/s12105-018-0935-1
doi: 10.1007/s12105-018-0935-1 pubmed: 29876739
Baneckova M, Agaimy A, Andreasen S et al (2018) Mammary analog secretory carcinoma of the nasal cavity: characterization of 2 cases and their distinction from other low-grade sinonasal denocarcinomas. Am J Surg Pathol 42:735–743. https://doi.org/10.1097/PAS.0000000000001048
doi: 10.1097/PAS.0000000000001048 pubmed: 29543674
Cipriani NA, Blair EA, Finkle J et al (2017) Salivary gland secretory carcinoma with high-grade transformation, CDKN2A/B loss, distant metastasis, and lack of sustained response to crizotinib. Int J Surg Pathol 25:613–618. https://doi.org/10.1177/1066896917709350
doi: 10.1177/1066896917709350 pubmed: 28497708
Jin S, Ma H, He Y (2016) Preservation of facial nerve with adjuvant radiotherapy for recurrent mammary analogue secretory carcinoma of parotid gland. J Craniofac Surg 27:e364–e366. https://doi.org/10.1097/SCS.0000000000002622
doi: 10.1097/SCS.0000000000002622 pubmed: 27192652
Reynolds S, Shaheen M, Olson G et al (2016) A case of primary mammary analog secretory carcinoma (MASC) of the thyroid masquerading as papillary thyroid carcinoma: potentially more than a one off. Head Neck Pathol 10:405–413. https://doi.org/10.1007/s12105-016-0715-8
doi: 10.1007/s12105-016-0715-8 pubmed: 27075025 pmcid: 4972767
Levine P, Fried K, Krevitt LD et al (2014) Aspiration biopsy of mammary analogue secretory carcinoma of accessory parotid gland: another diagnostic dilemma in matrix-containing tumors of the salivary glands. Diagn Cytopathol 42:49–53. https://doi.org/10.1002/dc.22886
doi: 10.1002/dc.22886 pubmed: 22807408
Rastatter JC, Jatana KR, Jennings LJ, Melin-Aldana H (2012) Mammary analogue secretory carcinoma of the parotid gland in a pediatric patient. Otolaryngol Head Neck Surg 146:514–515. https://doi.org/10.1177/0194599811419044
doi: 10.1177/0194599811419044 pubmed: 21873597
Min F-H, Li J, Tao B-Q, et al (2021) Parotid mammary analogue secretory carcinoma: a case report and review of literature. World J Clin Cases 9:4052–4062. https://doi.org/10.12998/wjcc.v9.i16.4052
Morimoto M, Sato T, Takano M et al (2021) Secretory carcinoma under the buccal mucosa suspected of being a benign tumor. Journal of Oral and Maxillofacial Surgery, Medicine, and Pathology 33:188–192. https://doi.org/10.1016/j.ajoms.2020.10.008
doi: 10.1016/j.ajoms.2020.10.008
Numano Y, Ogawa T, Ishikawa T et al (2020) Parotid secretory carcinoma with high-grade transformation. Auris Nasus Larynx 47:1043–1048. https://doi.org/10.1016/j.anl.2019.10.003
doi: 10.1016/j.anl.2019.10.003 pubmed: 31679811
Boliere C, Murphy J, Qaisi M et al (2019) Mammary analogue secretory carcinoma of the palate: case report and review of the literature. Case Rep Dent 2019:7416302. https://doi.org/10.1155/2019/7416302
doi: 10.1155/2019/7416302 pubmed: 30937197 pmcid: 6415289
Takeda M, Kasai T, Morita K et al (2015) Cytopathological features of mammary analogue secretory carcinoma–review of literature. Diagn Cytopathol 43:131–137. https://doi.org/10.1002/dc.23146
doi: 10.1002/dc.23146 pubmed: 24652816
Luo W, Lindley SW, Lindley PH et al (2014) Mammary analog secretory carcinoma of salivary gland with high-grade histology arising in hard palate, report of a case and review of literature. Int J Clin Exp Pathol 7:9008–9022
pubmed: 25674280 pmcid: 4313953
Sethi R, Kozin E, Remenschneider A et al (2014) Mammary analogue secretory carcinoma: update on a new diagnosis of salivary gland malignancy. Laryngoscope 124:188–195. https://doi.org/10.1002/lary.24254
doi: 10.1002/lary.24254 pubmed: 23775296
Kaleem A, Patel N, Alzahrani S et al (2020) Concurrent presence of secretory carcinoma and Warthin’s tumor in ipsilateral parotid gland. Oral Oncol 109:104691. https://doi.org/10.1016/j.oraloncology.2020.104691
doi: 10.1016/j.oraloncology.2020.104691 pubmed: 32331963
Gonzalez MF, Akhtar I, Manucha V (2018) Additional diagnostic features of mammary analogue secretory carcinoma on cytology. Cytopathology 29:100–103. https://doi.org/10.1111/cyt.12465
doi: 10.1111/cyt.12465 pubmed: 28929545
Balanzá R, Arrangoiz R, Cordera F et al (2015) Mammary analog secretory carcinoma of the parotid gland: A case report and literature review. Int J Surg Case Rep 16:187–191. https://doi.org/10.1016/j.ijscr.2015.09.031
doi: 10.1016/j.ijscr.2015.09.031 pubmed: 26496413 pmcid: 4643465
Hyrcza MD, Andreasen S, Melchior LC et al (2018) Primary secretory carcinoma of the lacrimal gland: report of a new entity. Am J Ophthalmol 193:178–183. https://doi.org/10.1016/j.ajo.2018.06.019
doi: 10.1016/j.ajo.2018.06.019 pubmed: 29963997
Shibata E, Morita K-I, Kayamori K et al (2020) Secretory carcinoma around Stensen’s duct misdiagnosed as salivary duct cyst. Int J Clin Exp Pathol 13:2211–2217
pubmed: 32922622 pmcid: 7476943
Bill R, Deschler DG, Pittet MJ, et al (2021) Diagnostic challenges and successful organ-preserving therapy in a case of secretory carcinoma of minor salivary glands. Cancer Rep e1491. https://doi.org/10.1002/cnr2.1491
Carlson ER, Schlieve T (2019) Salivary Gland Malignancies. Oral Maxillofac Surg Clin North Am 31:125–144. https://doi.org/10.1016/j.coms.2018.08.007
doi: 10.1016/j.coms.2018.08.007 pubmed: 30449524
Hamamoto Y, Harada H, Kohara M et al (2021) Usefulness of immunohistochemistry to distinguish between secretory carcinoma and acinic cell carcinoma in the salivary gland. Med Mol Morphol 54:23–30. https://doi.org/10.1007/s00795-020-00256-4
doi: 10.1007/s00795-020-00256-4 pubmed: 32488412
Bishop JA, Yonescu R, Batista DAS et al (2013) Cytopathologic features of mammary analogue secretory carcinoma. Cancer Cytopathol 121:228–233. https://doi.org/10.1002/cncy.21245
doi: 10.1002/cncy.21245 pubmed: 23042752
Jung MJ, Song JS, Kim SY et al (2013) Finding and characterizing mammary analogue secretory carcinoma of the salivary gland. Korean J Pathol 47:36–43. https://doi.org/10.4132/KoreanJPathol.2013.47.1.36
doi: 10.4132/KoreanJPathol.2013.47.1.36 pubmed: 23483204 pmcid: 3589607
Alves LDB, de Melo AC, Farinha TA et al (2020) A systematic review of secretory carcinoma of the salivary gland: where are we? Oral Surg Oral Med Oral Pathol Oral Radiol. https://doi.org/10.1016/j.oooo.2020.04.007
doi: 10.1016/j.oooo.2020.04.007 pubmed: 33741283
Ngouajio AL, Drejet SM, Phillips DR et al (2017) A systematic review including an additional pediatric case report: pediatric cases of mammary analogue secretory carcinoma. Int J Pediatr Otorhinolaryngol 100:187–193. https://doi.org/10.1016/j.ijporl.2017.07.004
doi: 10.1016/j.ijporl.2017.07.004 pubmed: 28802370
Sawabe M, Ito H, Takahara T et al (2018) Heterogeneous impact of smoking on major salivary gland cancer according to histopathological subtype: a case-control study. Cancer 124:118–124. https://doi.org/10.1002/cncr.30957
doi: 10.1002/cncr.30957 pubmed: 28881386
Speight PM (1992) World health organization international histological classification of tumours: histological typing of salivary gland tumours. G. Seifert (Ed.). Springer-Verlag, Heidelberg, 1991. No. of pages: 112. Price: DM 68. ISBN: 0 387 54031. The Journal of Pathology 168:88–88
Hsieh M-S, Chou Y-H, Yeh S-J, Chang Y-L (2015) Papillary-cystic pattern is characteristic in mammary analogue secretory carcinomas but is rarely observed in acinic cell carcinomas of the salivary gland. Virchows Arch 467:145–153. https://doi.org/10.1007/s00428-015-1786-8
doi: 10.1007/s00428-015-1786-8 pubmed: 25976476
Skalova A, Michal M, Simpson RH (2017) Newly described salivary gland tumors. Mod Pathol 30:S27–S43. https://doi.org/10.1038/modpathol.2016.167
doi: 10.1038/modpathol.2016.167 pubmed: 28060365
Tartaglione T, Botto A, Sciandra M, et al (2015) Differential diagnosis of parotid gland tumours: which magnetic resonance findings should be taken in account? Acta Otorhinolaryngol Ital 35:314–320. https://doi.org/10.14639/0392-100X-693
Minami M, Tanioka H, Oyama K et al (1993) Warthin tumor of the parotid gland: MR-pathologic correlation. AJNR Am J Neuroradiol 14:209–214
pubmed: 8427092 pmcid: 8334432
Baba A, Kessoku H, Akutsu T et al (2021) Correction to: pre-treatment MRI predictor of high-grade malignant parotid gland cancer. Oral Radiol. https://doi.org/10.1007/s11282-021-00512-y
doi: 10.1007/s11282-021-00512-y pubmed: 33686577
Ishibashi M, Fujii S, Kawamoto K et al (2010) Capsule of parotid gland tumor: evaluation by 3.0 T magnetic resonance imaging using surface coils. Acta radiol 51:1103–1110. https://doi.org/10.3109/02841851.2010.519716
doi: 10.3109/02841851.2010.519716 pubmed: 20883183

Auteurs

Ryo Kurokawa (R)

Division of Neuroradiology, Department of Radiology, University of Michigan, 1500 E Medical Center Dr, UH B2, Ann Arbor, MI, 48109, USA. kuroro63@gmail.com.

Mariko Kurokawa (M)

Division of Neuroradiology, Department of Radiology, University of Michigan, 1500 E Medical Center Dr, UH B2, Ann Arbor, MI, 48109, USA.

Akira Baba (A)

Division of Neuroradiology, Department of Radiology, University of Michigan, 1500 E Medical Center Dr, UH B2, Ann Arbor, MI, 48109, USA.

Yoshiaki Ota (Y)

Division of Neuroradiology, Department of Radiology, University of Michigan, 1500 E Medical Center Dr, UH B2, Ann Arbor, MI, 48109, USA.

Toshio Moritani (T)

Division of Neuroradiology, Department of Radiology, University of Michigan, 1500 E Medical Center Dr, UH B2, Ann Arbor, MI, 48109, USA.

Ashok Srinivasan (A)

Division of Neuroradiology, Department of Radiology, University of Michigan, 1500 E Medical Center Dr, UH B2, Ann Arbor, MI, 48109, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH